Skip to main content

Advertisement

SpringerLink
Log in

Multiple myeloma: a descriptive study of 217 Egyptian patients

  • Original Article
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Abstract

Multiple myeloma is a neoplasm of plasma cells that results in the overproduction of light and heavy chain monoclonal immunoglobulins. The incidence rate increases with age, particularly after 40 years, and is higher in men. To determine the clinical and laboratory characteristics and survival of diagnosed Egyptian multiple myeloma patients admitted to the Haemato-Oncology Department between 2000 and 2010. Records of all patients in whom multiple myeloma was diagnosed at the Kasr Al Aini Hospital between 2000 and 2010 were included in this retrospective study. The mean age of patients was 58.5 years (range, 27–80 years). Fifty-nine percent were males. The majority of patients (73 %) had an immunoglobulin G monoclonal band and 70 % were Kappa chain-positive. Mean overall survival was 37.5 months (range, 1–84 months). Survival analysis was statistically insignificant with respect to age, sex, International Staging System and type of treatment (p > 0.05). Our records were largely comparable to those reported in Chinese studies but different from those noted in Western and Arabic countries.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Alexander DD, Mink PJ, Adami H-O, Cole P, Mandel JS, Oken MM, Trichopoulos D (2007) Multiple myeloma: a review of the epidemiologic literature. Int J Cancer 120:40–61

    Article  PubMed  Google Scholar 

  2. Kyle RA, Rajkumar SV (2007) Epidemiology of the plasma-cell disorders. Best Practice Res Clin Haematol 20(4):637–664

    Article  CAS  Google Scholar 

  3. Wallin A, Larsson SC (2011) Body mass index and risk of multiple myeloma: a meta-analysis of prospective studies. Eur J Cancer 2011(47):1606–1615

    Article  Google Scholar 

  4. Zandecki M, Lai JL, Facon T (1996) Multiple myeloma: almost all patients are cytogenetically abnormal. Br J Haematol 94:217–227

    Article  CAS  PubMed  Google Scholar 

  5. Barlogie B, Sawyer J, Ayers D et al (1998) Chromosome 13 myeloma is a distinct entity with poor prognosis despite tandem autotransplants. Blood 92:259A

    Google Scholar 

  6. British Committee for Standardisation in Haematology (2011) Guideline, diagnosis and management of multiple myeloma. Br J Haematol 115:522–540

    Google Scholar 

  7. Avet LH, Li JY, Morineau N et al (1999) Monosomy 13 is associated with the transition of monoclonal gammopathy of undetermined significance to multiple myeloma. Blood 94:2583–2589

    Google Scholar 

  8. Dimopoulos MA et al (2009) International Myeloma Working Group (IMWG) consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple myeloma. Leukemia 23(9):1545–1556

    Article  CAS  PubMed  Google Scholar 

  9. Qiu L, Wang Y, Qi P, Zou D, Zhao Y, Qi J (2008) Clinical epidemiological study on multiple myeloma in China: a 18-year retrospective study in a representative center. ASH 50th Annual Meeting. December 7, 2008. poster N 2723

  10. Hjorth M, Holmberg E, Roder S, Westin J, Myeloma Group of Western Sweden (1992) Impact of active and passive exclusions on the results of a clinical trial in multiple myeloma. Br J Haematol 80:55–61

    Article  CAS  PubMed  Google Scholar 

  11. Sirohi B, Powles R (2006) Epidemiology and outcomes research for MGUS, myeloma and amyloidosis. Eur J Cancer 42:1671–1683

    Article  PubMed  Google Scholar 

  12. Phekoo KJ, Schey SA, Richards MA, Bevan DH, Bell S, Gillett D, Møller H (2004) A population study to define the incidence and survival of multiple myeloma in a National Health Service Region in UK. Br J Haematol 127(3):299–304

    Article  CAS  PubMed  Google Scholar 

  13. Steineck G, Wiklund K (1986) Multiple myeloma in Swedish agricultural workers. Int J Epidemiol 15(3):321–325

    Article  CAS  PubMed  Google Scholar 

  14. Mseddi-Hdiji S, Haddouk S, Ben Ayed M, Tahri N, Elloumi M, Baklouti S, Hachicha J, Krichen MS, Bahloul Z, Masmoudi H (2005) Monoclonal gammopathies in Tunisia: epidemiological, immunochemical and etiological analysis of 288 cases. Pathol Biol (Paris) 53(1):19–25

    Article  CAS  Google Scholar 

  15. Khalil SH et al (1991) Multiple myeloma: a review of 92 cases at King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia. Ann Saudi Med 11:642–646

    CAS  PubMed  Google Scholar 

  16. Amrani Hassani M, Filali Baba A, Alami M, Lahlou H (2010) Laboratory diagnostic and prognostic factors: multiple myeloma in Morocco. Sante 20(4):209–213

    PubMed  Google Scholar 

  17. Spasov E, Goranova V (1998) Prognostic assessment of the Durie and Salmon staging system in patients with multiple myeloma. Folia Med (Plovdiv) 40(3B Suppl 3):121–123

    CAS  Google Scholar 

  18. Kyle RA, Gertz MA, Witzig TE, Lust JA, Lacy MQ, Dispenzieri A, Fonseca R, Rajkumar SV, Offord JR, Larson DR, Plevak ME, Therneau TM, Greipp PR (2003) Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc 78(1):21–33

    Article  PubMed  Google Scholar 

  19. Gebregziabher M, Bernstein L, Wang Y, Cozen W (2006) Risk patterns of multiple myeloma in Los Angeles County, 1972–1999 (United States). Cancer Causes Control 17(7):931–938

    Article  PubMed  Google Scholar 

  20. Herrinton LJ, Weiss NS, Olshan AF (2013) Multiple myeloma. In: Schottenfeld D, Fraumeni JF (eds) Cancer epidemiology and prevention, 2nd edn. WB Saunders, Philadelphia

    Google Scholar 

  21. Kaya H, Peressini B, Jawed I, Martincic D, Elaimy AL, Lamoreaux WT, Fairbanks RK, Weeks KA, Lee CM (2012) Impact of age, race and decade of treatment on overall survival in a critical population analysis of 40,000 multiple myeloma patients. Int J Hematol 95:64–70

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

We are grateful to all the nurses and workers in the Oncology and Haematology Departments of Cairo University.

Author information

Authors and Affiliations

  1. Clinical Haematology Unit, Kasr Al Aini Hospital, Cairo University, Giza, Egypt

    Noha M. El Husseiny & Mervat W. Mattar

  2. Clinical Pathology Unit, Kasr Al Aini Hospital, Cairo University, Giza, Egypt

    Neemat Kasem

  3. National Oncology Unit, Kasr Al Aini Hospital, Cairo University, Giza, Egypt

    Hamdy Abd El Azeeim

Authors
  1. Noha M. El Husseiny
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Neemat Kasem
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hamdy Abd El Azeeim
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mervat W. Mattar
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Noha M. El Husseiny.

Rights and permissions

Reprints and permissions

About this article

Cite this article

El Husseiny, N.M., Kasem, N., El Azeeim, H.A. et al. Multiple myeloma: a descriptive study of 217 Egyptian patients. Ann Hematol 93, 141–145 (2014). https://doi.org/10.1007/s00277-013-1849-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-013-1849-3

Keywords

Search

Navigation